Mrs. Sandra Saldanha has been re-appointed as a Whole-time Director of Marksans Pharma Ltd for a further period of three years, effective from September 25, 2023.
She holds a Master Degree in Arts (Sociology) and has extensive experience in Human Resource Management, Business Development, Projects, and Supply Chain Management.
As of March 31, 2023, she holds 220,180 equity shares in the company, indicating a significant financial interest.
Her first appointment to the Board was on September 25, 2014, and she has drawn a remuneration of ₹70,29,564 in the last fiscal year.
Sandra Saldanha is currently a Whole-time Director in Marksans Pharma Ltd (as of Mar 2024).
Sandra Saldanha is serving the company - Marksans Pharma Ltd at this position since 2019 for the last 7+ years.
Prior to becoming Whole-time Director, Sandra Saldanha was director of Marksans Pharma Ltd for 2 years from 2015 to 2016.
FAQ's related Sandra Saldanha
Who is Sandra Saldanha
Mrs. Sandra Saldanha has been re-appointed as a Whole-time Director of Marksans Pharma Ltd for a further period of three years, effective from September 25, 2023. She holds a Master Degree in Arts (Sociology) and has extensive experience in Human Resource Management, Business Development, Projects, and Supply Chain Management. As of March 31, 2023, she holds 220,180 equity shares in the company, indicating a significant financial interest. Her first appointment to the Board was on September 25, 2014, and she has drawn a remuneration of ₹70,29,564 in the last fiscal year.
Which companies does Sandra Saldanha serve as a board member for?
Sandra Saldanha serves as a board member for: Marksans Pharma Ltd
What positions has Sandra Saldanha held in his/her career?
Throughout their career, Sandra Saldanha has held key positions such as Whole-time Director,director, contributing to the growth and success of each company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.